| Product Code: ETC13238483 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global AI In Genomics Market was valued at USD 1.4 Billion in 2024 and is expected to reach USD 5 Billion by 2031, growing at a compound annual growth rate of 17.80% during the forecast period (2025-2031).
The global AI in genomics market is experiencing significant growth driven by the increasing adoption of AI technology in genomics research and personalized medicine. AI solutions are being utilized to analyze vast amounts of genomic data quickly and accurately, enabling researchers to identify patterns, make predictions, and discover potential therapeutic targets. Key market players are developing AI algorithms and platforms that can interpret genetic data to improve disease diagnosis and treatment outcomes. The integration of AI in genomics is revolutionizing the healthcare industry by enabling precision medicine approaches and facilitating more targeted and effective treatments. Factors such as the growing prevalence of genetic disorders, advancements in AI technology, and the rise of collaborations between biotech companies and AI developers are expected to further propel the market`s expansion in the coming years.
The global AI in genomics market is experiencing rapid growth due to the increasing adoption of AI technologies in genomics research and personalized medicine. Key trends include the use of machine learning algorithms to analyze large genomic datasets, the development of AI-powered tools for genomic data interpretation, and the integration of AI with other technologies such as CRISPR for gene editing. Opportunities in this market lie in the development of AI-driven diagnostics for precision medicine, drug discovery, and the advancement of genomic sequencing technologies. The market is also witnessing collaborations between AI companies and genomics research institutions to accelerate innovation in this space. Overall, the global AI in genomics market is poised for significant expansion with the potential to revolutionize healthcare and biotechnology industries.
The Global AI in Genomics market faces several challenges, including the complexity of integrating AI technologies into existing genomics workflows, the need for large and diverse datasets to train AI models effectively, and the ongoing ethical and regulatory concerns surrounding the use of AI in genomics research and healthcare. Additionally, there is a shortage of skilled professionals who can effectively leverage AI tools in genomics, leading to a talent gap in the industry. Moreover, the high costs associated with implementing AI solutions and the potential for bias in AI algorithms further complicate the adoption and utilization of AI in genomics. Overcoming these challenges will require collaboration among researchers, industry stakeholders, policymakers, and ethicists to ensure the responsible and effective integration of AI in genomics applications.
The Global AI in Genomics Market is primarily driven by the increasing adoption of precision medicine and personalized healthcare solutions, which utilize AI algorithms to analyze vast genomic datasets for better disease diagnosis, treatment, and drug discovery. The growing need for efficient data processing and interpretation in genomics research, coupled with advancements in AI technologies such as machine learning and deep learning, are also key drivers propelling market growth. Additionally, the rising demand for genomic sequencing services, along with government initiatives and funding to support genomics research, further contribute to the expansion of the AI in genomics market. The ability of AI to accelerate genomic data analysis, identify patterns, and predict outcomes is revolutionizing the field of genomics and driving its integration with artificial intelligence technologies.
Government policies related to the Global AI in Genomics Market vary across countries, with a focus on regulating data privacy, promoting innovation, and ensuring ethical use of AI technologies. In the United States, the FDA has released guidelines for AI-based medical devices, while in the European Union, the General Data Protection Regulation (GDPR) governs the handling of genomic data. Countries like China have launched national initiatives to advance AI in genomics, while others, such as Japan, are investing in research and development in this field. Overall, governments are striving to strike a balance between fostering technological advancements and safeguarding patient privacy and ethical considerations in the rapidly evolving AI in genomics market.
The Global AI in Genomics Market is expected to witness significant growth in the coming years as advancements in AI technology continue to revolutionize genomics research and healthcare. The integration of AI algorithms in genomics data analysis is enhancing the speed, accuracy, and efficiency of genomic sequencing, interpretation, and personalized medicine. This market is projected to expand due to the rising demand for precision medicine, increased investments in genomics research, and the growing adoption of AI tools in healthcare. Key players are focusing on developing innovative AI solutions for genomics, which will drive market growth further. However, challenges such as data privacy concerns and regulatory hurdles may impact market growth. Overall, the Global AI in Genomics Market is poised for substantial expansion and innovation in the foreseeable future.
In the Global AI in Genomics Market, Asia is expected to witness significant growth due to the increasing adoption of advanced technologies in countries like China and India. North America leads the market with a strong presence of key players and substantial investments in AI-driven genomics research. Europe follows closely behind, driven by advancements in healthcare infrastructure and government initiatives supporting genomics research. The Middle East and Africa region is gradually embracing AI in genomics, with growing awareness about precision medicine and personalized healthcare. Latin America is also showing promise with rising investments in healthcare and research infrastructure, indicating a potential growth opportunity for AI in genomics in the region.
Global AI In Genomics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global AI In Genomics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global AI In Genomics Market Revenues & Volume, 2021 & 2031F |
3.3 Global AI In Genomics Market - Industry Life Cycle |
3.4 Global AI In Genomics Market - Porter's Five Forces |
3.5 Global AI In Genomics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global AI In Genomics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Global AI In Genomics Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.8 Global AI In Genomics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global AI In Genomics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global AI In Genomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global AI In Genomics Market Trends |
6 Global AI In Genomics Market, 2021 - 2031 |
6.1 Global AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global AI In Genomics Market, Revenues & Volume, By Machine Learning, 2021 - 2031 |
6.1.3 Global AI In Genomics Market, Revenues & Volume, By Computer Vision, 2021 - 2031 |
6.2 Global AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global AI In Genomics Market, Revenues & Volume, By Hardware, 2021 - 2031 |
6.2.3 Global AI In Genomics Market, Revenues & Volume, By Software, 2021 - 2031 |
6.2.4 Global AI In Genomics Market, Revenues & Volume, By Services, 2021 - 2031 |
6.3 Global AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global AI In Genomics Market, Revenues & Volume, By Drug Discovery and Development, 2021 - 2031 |
6.3.3 Global AI In Genomics Market, Revenues & Volume, By Precision Medicine, 2021 - 2031 |
6.3.4 Global AI In Genomics Market, Revenues & Volume, By Diagnostics, 2021 - 2031 |
6.3.5 Global AI In Genomics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global AI In Genomics Market, Revenues & Volume, By Pharmaceutical and Biotech Companies, 2021 - 2031 |
6.4.3 Global AI In Genomics Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.4.4 Global AI In Genomics Market, Revenues & Volume, By Research Centers, 2021 - 2031 |
7 North America AI In Genomics Market, Overview & Analysis |
7.1 North America AI In Genomics Market Revenues & Volume, 2021 - 2031 |
7.2 North America AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
7.5 North America AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) AI In Genomics Market, Overview & Analysis |
8.1 Latin America (LATAM) AI In Genomics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.4 Latin America (LATAM) AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
8.5 Latin America (LATAM) AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia AI In Genomics Market, Overview & Analysis |
9.1 Asia AI In Genomics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.4 Asia AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
9.5 Asia AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa AI In Genomics Market, Overview & Analysis |
10.1 Africa AI In Genomics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.4 Africa AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
10.5 Africa AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe AI In Genomics Market, Overview & Analysis |
11.1 Europe AI In Genomics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.4 Europe AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
11.5 Europe AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East AI In Genomics Market, Overview & Analysis |
12.1 Middle East AI In Genomics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East AI In Genomics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey AI In Genomics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East AI In Genomics Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.4 Middle East AI In Genomics Market, Revenues & Volume, By Offering, 2021 - 2031 |
12.5 Middle East AI In Genomics Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East AI In Genomics Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global AI In Genomics Market Key Performance Indicators |
14 Global AI In Genomics Market - Export/Import By Countries Assessment |
15 Global AI In Genomics Market - Opportunity Assessment |
15.1 Global AI In Genomics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global AI In Genomics Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.3 Global AI In Genomics Market Opportunity Assessment, By Offering, 2021 & 2031F |
15.4 Global AI In Genomics Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global AI In Genomics Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global AI In Genomics Market - Competitive Landscape |
16.1 Global AI In Genomics Market Revenue Share, By Companies, 2024 |
16.2 Global AI In Genomics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here